Shares of Hims & Hers Health (NYSE: HIMS) have been on fire over the past year, but they're not expensive by most valuation ...

Hims & Hers Health (NYSE: HIMS) reported another blowout quarter recently, but the stock didn't get the type of pop that ...

Digital health companies faced high advertising costs and focused on returns on investments in the third quarter.

Last week, Hims & Hers Health (NYSE:HIMS) dropped another mic with its latest earnings, and the numbers are mind-blowing.

Investors with a lot of money to spend have taken a bullish stance on Hims & Hers Health HIMS. And retail traders should know. We noticed this today when the trades showed up on publicly available ...

Analyzing H&H's Q3 results and investment strategy in the healthcare industry, highlighting undervaluation and raising the ...

On Friday, Hims & Hers Health Inc (HIMS) stock saw a decline, ending the day at $23.41 which represents a decrease of $-0.21 or -0.89% from the prior close of $23.62. The stock opened at $23.6 and ...

Hims & Hers (HIMS) stock price remained on edge even after the fast-growing telehealth company published strong financial ...

Hims & Hers is revolutionizing telehealth and wellness for millennials and Gen Z with rapid revenue growth and positive net ...

Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, ...

To quote a 2014 paper by Lewellen and Resutek, "firms with higher accruals tend to be less profitable in the future". Hims & Hers Health has an accrual ratio of -0.32 for the year to September 2024.

Shares of Hims & Hers Health, Inc. (NYSE:HIMS – Get Free Report) reached a new 52-week high on Monday after TD Cowen raised their price target on the stock from $25.00 to $28.00. TD Cowen currently ...